Baidu
map

Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA

Ye, LF; Huang, ZY; Chen, XX; Chen, ZG; Wu, SX; Ren, C; Hu, MT; Bao, H; Jin, Y; Wang, F; Wang, FH; Du, ZM; Wu, X; Ju, HQ; Shao, Y; Li, YH; Xu, RH; Wang, DS

Li, YH; Xu, RH; Wang, DS (通讯作者)，Chinese Acad Med Sci, Res Unit Precis Diag & Treatment Gastrointestinal, Guangzhou 510060, Peoples R China.;Li, YH; Xu, RH; Wang, DS (通讯作者)，Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol, State Key Lab Oncol South China,Canc Ctr, 651 Dong Feng East Rd, Guangzhou 510060, Peoples R China.

DRUG RESISTANCE UPDATES, 2022; 65 ():

Abstract

Aims: This study aimed to identify mechanisms of drug resistance to the combination of vemurafenib, irinotecan, and cetuximab (VIC) in BRAFV600E metas......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map